Home Analyst Ratings

Analyst Ratings

Random

Analyst Upgrades – NASDAQ:FB – Facebook, Inc. Common (NASDAQ:FB) Stock Gets Upgraded By OTR Global from Positive to

ME Staff - June 5, 2018

ABB Ltd (NYSE:ABB) gets upgraded to Buy by HSBC

Analyst Activity – Morgan Stanley Raises Its Price Target On NASDAQ:FSLR – First Solar (NASDAQ:FSLR) to $64.00

Analyst Activity – Morgan Stanley Lowers Its Price Target On National Grid plc (LON:NG) to GBX 1,100

AutoZone, Inc. (NYSE:AZO) price target raised to $900.00 by Morgan Stanley

Banco Santander-Chile (ADR) (NYSE:BSAC) gets upgraded to Buy by JPMorgan Chase...

ME Staff - September 6, 2018

Analyst Activity – DA Davidson Initiates Coverage On NYSE:IEX – IDEX...

ME Staff - April 12, 2018

Analyst Activity – BMO Capital Markets Reiterates Buy on NYSE:MRK –...

ME Staff - April 16, 2018

Analyst Activity – Credit Suisse Group Reiterates Neutral on Chipotle Mexican...

ME Staff - January 23, 2018

Analyst Activity – DZ Bank Reiterates Buy on DB – Deutsche...

ME Staff - April 4, 2018

Analyst Activity – Roth Capital Reiterates Buy ➝ Neutral on NYSE:MXL...

ME Staff - June 11, 2018

Analyst Activity – Citigroup Lowers Its Price Target On NYSE:ALV –...

ME Staff - May 8, 2018

Analyst Activity – Morgan Stanley Lowers Its Price Target On Duke...

ME Staff - March 8, 2018

Analyst Activity – Piper Jaffray Companies Initiates Coverage On Core Laboratories...

ME Staff - March 13, 2018

Analyst Downgrades – NYSE:XHR – Xenia Hotels & Resorts (NYSE:XHR) Stock...

ME Staff - June 8, 2018

12 3...2,139 Page 1 of 2,139

/* */

EDITOR PICKS

Cannabis Stock News Daily Roundup July 15

July 15, 2019

Market Morning: Gilead Moves On Galapagos, Hong Kong Keeps Fighting, Trump...

July 15, 2019

Cannabis Stock News Daily Roundup July 12

July 12, 2019

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.